Rare Cancers Bill 2024-2025
The Rare Cancers Bill 2024-2025 had its second reading on Friday 14 March 2025. It was considered in Public Bill Committee on 2 July 2025 and report stage is scheduled for 11 July 2025. This is a private members' bill.

The Coronavirus Bill (Bill 122 of 2019-21) was introduced to the House of Commons on 19 March 2020. The Bill is part of the Government's response to the covid-19 pandemic. This paper provides a background to the Bill, and detail on the final provision of the Bill.
Coronavirus Bill: Background (217 KB , PDF)
This briefing paper is one of a collection of Commons Library briefings on the Coronavirus Bill (the Bill). It deals with the reason for the Bill and the final provisions around commencement, expiry and regulation making powers. The other briefing papers, dealing with other parts of the Bill and general background, are available on the Commons Library website (Coronavirus Bill: Overview).
The paper includes a background to Coronavirus, information on what the virus is and sources for statistics on the UK.
The paper also outlines briefly the Government response to date, including the Coronavirus action plan, the UK moving from the contain to delay stage, and the introduction of the Helath Protection (Coronavirus) Regulations 2020.
Details on the final provisions of the Bill are included (clauses 71-87), in particular covering commencement, territorial extent and the sunset clause. This clause means the legislation would only stay in force for two years, but is subject to provisions that allow for a shortening, or an extension of up to six months at a time.
Coronavirus Bill: Background (217 KB , PDF)
The Rare Cancers Bill 2024-2025 had its second reading on Friday 14 March 2025. It was considered in Public Bill Committee on 2 July 2025 and report stage is scheduled for 11 July 2025. This is a private members' bill.
This briefing focuses on two disease-modifying dementia drugs that are currently being appraised by the National Institute for Health and Care Excellence (NICE): lecanemab and donanemab
On 8 July 2025, there will be a Commons debate on alcohol and cancer. The debate will be led by Cat Smith MP. The Library will publish a briefing ahead of the debate.